Author
Listed:
- Viktor Janzen
(Massachusetts General Hospital, Harvard Medical School
Harvard University
University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute)
- Randolf Forkert
(Massachusetts General Hospital, Harvard Medical School
Harvard University
University of Pittsburgh School of Medicine, University of Pittsburgh Cancer Institute)
- Heather E. Fleming
(Massachusetts General Hospital, Harvard Medical School
Harvard University)
- Yoriko Saito
(Massachusetts General Hospital, Harvard Medical School
Harvard University)
- Michael T. Waring
(Massachusetts General Hospital, Harvard Medical School)
- David M. Dombkowski
(Massachusetts General Hospital, Harvard Medical School)
- Tao Cheng
(Massachusetts General Hospital, Harvard Medical School)
- Ronald A. DePinho
(Dana-Farber Cancer Institute, Departments of Medicine and Genetics, Harvard Medical School)
- Norman E. Sharpless
(The Lineberger Comprehensive Cancer Center, The University of North Carolina School of Medicine)
- David T. Scadden
(Massachusetts General Hospital, Harvard Medical School
Harvard University)
Abstract
Stem-cell ageing is thought to contribute to altered tissue maintenance and repair. Older humans experience increased bone marrow failure and poorer haematologic tolerance of cytotoxic injury. Haematopoietic stem cells (HSCs) in older mice have decreased per-cell repopulating activity, self-renewal and homing abilities, myeloid skewing of differentiation, and increased apoptosis with stress. Here we report that the cyclin-dependent kinase inhibitor p16INK4a, the level of which was previously noted to increase in other cell types with age, accumulates and modulates specific age-associated HSC functions. Notably, in the absence of p16INK4a, HSC repopulating defects and apoptosis were mitigated, improving the stress tolerance of cells and the survival of animals in successive transplants, a stem-cell-autonomous tissue regeneration model. Inhibition of p16INK4a may ameliorate the physiological impact of ageing on stem cells and thereby improve injury repair in aged tissue.
Suggested Citation
Viktor Janzen & Randolf Forkert & Heather E. Fleming & Yoriko Saito & Michael T. Waring & David M. Dombkowski & Tao Cheng & Ronald A. DePinho & Norman E. Sharpless & David T. Scadden, 2006.
"Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a,"
Nature, Nature, vol. 443(7110), pages 421-426, September.
Handle:
RePEc:nat:nature:v:443:y:2006:i:7110:d:10.1038_nature05159
DOI: 10.1038/nature05159
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:443:y:2006:i:7110:d:10.1038_nature05159. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.